N

Nouvelle Clinical Research | Cutler Bay, FL

Research site

(Unclaimed)

Location

10700 Caribbean Boulevard Suite 400, Cutler Bay, Florida, United States of America

Site insights

Top conditions

Top treatments

Apixaban

AD109

REGN7508

Atomoxetine

REGN9933

Allopurinol

AP1189

Tc 99m

Aroxybutynin

Lorundrostat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

The study is a randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral A...

Enrolling

Rheumatoid Arthritis (RA)

Drug: AP1189, 70 mg

Drug: AP1189 matching placebo

Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer)

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure...

Enrolling

Diastolic Heart Failure

Heart Failure With Preserved Ejection Fraction

Device: OPTIMIZER™ Smart Mini System

Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation (ROXI-ATLAS)

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which m...

Enrolling

Atrial Fibrillation (AF)

Drug: REGN9933

Drug: REGN7508

Locations recently updated

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation (ROXI-EVEREST)

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. T...

Enrolling

Atrial Fibrillation (AF)

Drug: Placebo

Drug: Apixaban